메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Anjani Qonita Kurnia (School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, UK) Demartis Sara (Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, Italy) Moreno-Castellanos Natalia (Basic Science Department, Faculty of Health, Universidad Industrial de Santander, Colombia) Gavini Elisabetta (Department of Medicine, Surgery and Pharmacy, University of Sassari, Italy) Donnelly Ryan F. (School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, UK)
저널정보
한국약제학회 Journal of Pharmaceutical Investigation Journal of Pharmaceutical Investigation Vol.54 No.5
발행연도
2024.9
수록면
683 - 698 (16page)
DOI
10.1007/s40005-024-00682-x

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose This investigation aims to develop and characterise dissolving microarray patches (MAPs) loaded with ivermectin (IVM) for rosacea therapy. Methods Tween® 80 and Soluplus® were evaluated to enhance the water solubility of IVM powder. Three dissolving MAPs were fabricated using a two-layer casting method, pure IVM-loaded (F1), IVM-Tween® 80 (F2), and IVM-Soluplus® (F3) loaded patches. Formulations were evaluated for drug content, in vitro and ex vivo mechanical performances, ex vivo skin dissolution time, dermatokinetics, in vitro biocompatibility and activity against rosacea. Results IVM solubility in water was improved with surfactants, reaching 1206.42 ± 53.78 and 130.78 ± 12.78 μg/mL in Tween® 80 and Soluplus® solutions, respectively. The MAPs, featuring bubble-free, perfectly shaped pyramidal needles of approximately 800 μm, exhibited considerably higher IVM content in F2 and F3 than in F1 (2.31 ± 0.26 mg for F1, 3.58 ± 0.15 mg for F2, and 3.19 ± 0.22 mg for F3). All formulations demonstrated mechanical robustness and penetrated the skin to a depth of 650 μm. The highest IVM deposition in the skin at 24 h was achieved by F2, selected as the lead formulation (F1 = 1456.35 ± 266.90 μg; F2 = 2165.24 ± 130.13 μg; F3 = 1684.74 ± 212.09 μg). Furthermore, F2 and F3 provided faster IVM deposition, most likely due to the quicker dissolution rate of microneedles in the skin. F2 proved biocompatible to skin cells in vitro and effectively inhibited the inflammatory cascade associated with rosacea diseases. Conclusion This study encourages further investigation into IVM-loaded dissolving MAPs formulated with Tween® 80 for rosacea therapy.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0